Monitoring therapy success of urogenital Chlamydia trachomatis infections in women: A prospective observational cohort study Article Swipe
Related Concepts
Chlamydia trachomatis
Azithromycin
Medicine
Asymptomatic
Chlamydia
Internal medicine
Multilocus sequence typing
Genitourinary system
Virology
Biology
Immunology
Microbiology
Genotype
Antibiotics
Genetics
Gene
Bart Versteeg
,
Sylvia M. Bruisten
,
Titia Heijman
,
W Vermeulen
,
Martijn S. van Rooijen
,
Alje P. van Dam
,
Maarten F. Schim van der Loeff
,
Henry J.C. de Vries
,
Maarten Scholing
·
YOU?
·
· 2017
· Open Access
·
· DOI: https://doi.org/10.1371/journal.pone.0185295
· OA: W2754825813
YOU?
·
· 2017
· Open Access
·
· DOI: https://doi.org/10.1371/journal.pone.0185295
· OA: W2754825813
Most RNA- or DNA-positive results after treatment of urogenital C. trachomatis may be caused by non-viable molecular remnants since they cannot be confirmed by culture. In a minority viable C. trachomatis was found in culture at the second visit, indicating that patients may remain infectious at least 7 days after treatment.
Related Topics
Finding more related topics…